Phospholipase A2 inhibitor and LY6/PLAUR domain-containing protein PINLYP regulates type I interferon innate immunity

Proc Natl Acad Sci U S A. 2022 Jan 4;119(1):e2111115119. doi: 10.1073/pnas.2111115119.

Abstract

Type I interferons (IFNs) are the first frontline of the host innate immune response against invading pathogens. Herein, we characterized an unknown protein encoded by phospholipase A2 inhibitor and LY6/PLAUR domain-containing (PINLYP) gene that interacted with TBK1 and induced type I IFN in a TBK1- and IRF3-dependent manner. Loss of PINLYP impaired the activation of IRF3 and production of IFN-β induced by DNA virus, RNA virus, and various Toll-like receptor ligands in multiple cell types. Because PINLYP deficiency in mice engendered an early embryonic lethality in mice, we generated a conditional mouse in which PINLYP was depleted in dendritic cells. Mice lacking PINLYP in dendritic cells were defective in type I IFN induction and more susceptible to lethal virus infection. Thus, PINLYP is a positive regulator of type I IFN innate immunity and important for effective host defense against viral infection.

Keywords: innate immunity; interferon; virus infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • DNA Virus Infections / genetics
  • DNA Virus Infections / immunology
  • DNA Viruses / genetics
  • DNA Viruses / immunology
  • Dendritic Cells / immunology*
  • Enzyme Inhibitors / immunology*
  • Humans
  • Immunity, Innate*
  • Interferon-beta / genetics
  • Interferon-beta / immunology*
  • Mice
  • Mice, Knockout
  • RNA Virus Infections / genetics
  • RNA Virus Infections / immunology
  • RNA Viruses / genetics
  • RNA Viruses / immunology

Substances

  • Enzyme Inhibitors
  • Interferon-beta